Related references
Note: Only part of the references are listed.Peroxisome proliferator-activated receptor-γ agonists suppress iNOS expression induced by LPS in rat primary Schwann cells
Fupeng Zhang et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
SSeCKS is a Suppressor in Schwann Cell Differentiation and Myelination
Yuhong Ji et al.
NEUROCHEMICAL RESEARCH (2010)
Protein kinase a-induced phosphorylation of the p65 subunit of nuclear Factor-κB promotes Schwann cell differentiation into a myelinating phenotype
Choya Yoon et al.
JOURNAL OF NEUROSCIENCE (2008)
The cyclin-dependent kinase inhibitor p57kip2 is a negative regulator of Schwann cell differentiation and in vitro myelination
Andre Heinen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Thiazolidinediones inhibit growth and invasiveness of the human adrenocortical cancer cell line H295R
P Ferruzzi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Beneficial effects of PPAR-γ ligands in ischemia-reperfusion injury, inflammation and shock
M Abdelrahman et al.
CARDIOVASCULAR RESEARCH (2005)
PPARs and the complex journey to obesity
RM Evans et al.
NATURE MEDICINE (2004)
Up-regulation of p21 gene expression by peroxisome proliferator-activated receptor γ in human lung carcinoma cells
SW Han et al.
CLINICAL CANCER RESEARCH (2004)
Neuronal differentiation of embryonic midbrain cells by upregulation of peroxisome proliferator-activated receptor-gamma via the JNK-dependent pathway
KS Park et al.
EXPERIMENTAL CELL RESEARCH (2004)
Be fit or be sick: Peroxisome proliferator-activated receptors are down the road
B Desvergne et al.
MOLECULAR ENDOCRINOLOGY (2004)
Activation of p38 mitogen-activated protein kinase and activator protein-1 during the promotion of neurite extension of PC-12 cells by 15-deoxy-Δ12,14-prostaglandin J2
KM Jung et al.
MOLECULAR PHARMACOLOGY (2003)
Natural ligands of PPARγ:: Are prostaglandin J2 derivatives really playing the part?
O Nosjean et al.
CELLULAR SIGNALLING (2002)
Divergent effects of selective peroxisome proliferator-activated receptor-γ2 ligands on adipocyte versus osteoblast differentiation
B Lecka-Czernik et al.
ENDOCRINOLOGY (2002)
PPARs: transcriptional effectors of fatty acids and their derivatives
AK Hihi et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2002)
Activation of peroxisome proliferator-activated receptor-γ stimulates the growth arrest and DNA-damage inducible 153 gene in non-small cell lung carcinoma cells
T Satoh et al.
ONCOGENE (2002)
Lack of replicative senescence in normal rodent glia
NF Mathon et al.
SCIENCE (2001)
PPAR-γ agonists:: therapeutic role in diabetes, inflammation and cancer
GJ Murphy et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2000)
Roles of PPARs in health and disease
S Kersten et al.
NATURE (2000)
Peroxisome proliferator-activated receptors: insight into multiple cellular functions
P Escher et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2000)
Share Paper
